Global Hemoconcentrators Market

Global Hemoconcentrators Market

Global Hemoconcentrators Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

A hemoconcentrator is a fluid removal device used during cardio bypass surgery. The device is inserted into the extracorporeal circuit to control hemodilution, maintain hematocrit levels, and reduce the need for additional blood products during and after surgery. Recognised as a great asset in fluid management, hemoconcentrators lower edema, organ dysfunction and protein concentration.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of renal diseases

The rising incidence of renal diseases worldwide necessitates surgical interventions, driving the demand for hemoconcentrators. These devices are essential in managing blood volume and composition during surgeries related to these diseases.

For instance, For every two women who develop kidney failure, three men develop kidney failure. However, kidney disease is more common in women than men (14.3% vs. 12.4%).

There are more than 90,000 Americans on the kidney transplant waiting list, but in 2022, just 26,309 — or about 1 in 4 — were able to get a kidney. There were 5,863 living donor transplants performed in the U.S. last year.

Furthermore, the global hemoconcentrators are also driven by various other factors like advancements in the devices, rise in advanced surgical procedures and others helping the market to grow during the forecast period.

Product Recalls

On the contrary, several risks and medical complexions related to hemoconcentrators, the dearth of skilled professionals and expertise in developing regions and the presence of substitutes for these devices are the hampering factors for the market development. Additionally, product recalls would also restrict the industry's growth.

Segment Analysis

The global hemoconcentrators market is segmented based on device type, indication, end-user and region.

The adult hemoconcentrators from the device type segment accounted for approximately 54.1% of the hemoconcentrators market share

The adult hemoconcentrators from the device type segment accounted for approximately 54.1%. The adult hemoconcentrator segment is expected to have the highest market share during the forecast period owing to one of the major factors bolstering the product adoption is the rising cases of obesity among older adults living in rural areas, as obesity can heighten the risk of heart failure.

For instance, according to the annual report by the Trust for America's Health (TFAH), in 2022, 19 states in the U.S. saw their obesity rates surpass 35%. This aspect will spur the usage of adult hemoconcentrators to carry out cardiac surgery in obese patients, further bolstering the market expansion.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to the factors like the rise in prevalence of cardiovascular diseases, increasing number of surgeries and demand for advanced cardiopulmonary bypass equipment are driving regional growth. The risk of developing cardiopulmonary diseases in the US is rising due to changing lifestyles and an ageing population, indicating a growing need for hemoconcentrators to prevent and treat chronic diseases.

For instance, according to the Centers for Disease Control and Prevention where heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 33 seconds in the United States from cardiovascular disease. About 695,000 people in the United States died from heart disease in 2021—that’s 1 in every 5 deaths.

Covid 19 Impact Analysis

The pandemic has raised concerns about blood supply shortages due to decreased donations and disruptions in blood collection processes, prompting increased focus on blood conservation strategies during surgeries.

Market Segmentation

By Device Type
• Pediatric Hemoconcentrators
• Adult Hemoconcentrators

By Indication
• Cardiovascular Diseases
• Renal Diseases
• Others

By End User
• Hospitals
• Ambulatory Surgical Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Medivators Inc, Getinge, Terumo Cardiovascular Systems Corporation, LivaNova plc, Medica s.p.a, Medtronic plc, Nipro, Braile Biomédica, Sorin Group, Avoma Group among others.

Why Purchase the Report?
• To visualize the global hemoconcentrators market segmentation based on device type, indication, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of hemoconcentrators market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global hemoconcentrators market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies